Home » Stocks » 111, Inc.

111, Inc. (YI)

Stock Price: $6.82 USD -0.18 (-2.57%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 569.10M
Revenue (ttm) 564.58M
Net Income (ttm) -499.61M
Shares Out 46.36M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $6.82
Previous Close $7.00
Change ($) -0.18
Change (%) -2.57%
Day's Open 6.88
Day's Range 6.80 - 7.07
Day's Volume 48,024
52-Week Range 4.43 - 8.70

More Stats

Market Cap 569.10M
Enterprise Value 487.79M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 46.36M
Float n/a
EPS (basic) n/a
EPS (diluted) -1.27
FCF / Share -0.93
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 60,880
Short Ratio 0.72
Short % of Float n/a
Beta 1.21
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.01
PB Ratio 6.45
Revenue 564.58M
Operating Income -70.50M
Net Income -499.61M
Free Cash Flow -76.03M
Net Cash 81.32M
Net Cash / Share 0.97
Gross Margin 4.18%
Operating Margin -12.49%
Profit Margin -12.60%
FCF Margin -13.47%
ROA -16.99%
ROE -61.54%
ROIC -151.00%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $6.82
Target: 12.38
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Revenue Growth121.28%86.14%9.8%-
Gross Profit16510490.7777.61
Operating Income-494-400-254-364
Net Income-500-380-249-363
Shares Outstanding16499.4572.0072.00
Earnings Per Share-6.10-7.64-6.90-11.62
Operating Cash Flow-512-343-204-389
Capital Expenditures-19.85-14.34-6.74-5.07
Free Cash Flow-532-357-211-394
Cash & Equivalents7211,107461640
Total Debt152---
Net Cash / Debt5691,107461640
Book Value7771,224-946-692
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name 111, Inc.
Country China
Employees 1,932
CEO Jun Ling Liu

Stock Information

Ticker Symbol YI
Stock Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Unique Identifier NASDAQ: YI


111, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2019, it operated 12 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Shanghai, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has a strategic partnership with Bayer Healthcare Co. Ltd. to develop a digitalized content portal that would provide online pharmacist training and interactive patient education content and services. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.